These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 29730129
21. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A. J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571 [Abstract] [Full Text] [Related]
22. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans. Ng SM, Yap YY, Cheong JW, Ng FM, Lau QY, Barkham T, Teo JW, Hill J, Chia CS. J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725 [Abstract] [Full Text] [Related]
23. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy. Shahid Z, Sobel JD. Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794 [Abstract] [Full Text] [Related]
24. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates]. Oz Y, Akşit F, Kiraz N, Kiremitçi A. Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574 [Abstract] [Full Text] [Related]
25. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole. Huang S, Cao YY, Dai BD, Sun XR, Zhu ZY, Cao YB, Wang Y, Gao PH, Jiang YY. Biol Pharm Bull; 2008 Dec; 31(12):2234-6. PubMed ID: 19043205 [Abstract] [Full Text] [Related]
29. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, Li L, Deng X, Yu L. Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969 [Abstract] [Full Text] [Related]
35. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression. Zhang JY, Liu JH, Liu FD, Xia YH, Wang J, Liu X, Zhang ZQ, Zhu N, Yan-Yan, Ying Y, Huang XT. Mycoses; 2014 Oct 21; 57(10):584-91. PubMed ID: 24962255 [Abstract] [Full Text] [Related]
36. A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance in Candida albicans. Peralta MA, Calise M, Fornari MC, Ortega MG, Diez RA, Cabrera JL, Pérez C. Planta Med; 2012 Jun 21; 78(10):981-7. PubMed ID: 22673834 [Abstract] [Full Text] [Related]
38. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY. Antimicrob Agents Chemother; 2006 Mar 21; 50(3):1096-9. PubMed ID: 16495278 [Abstract] [Full Text] [Related]
39. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans. Endo EH, Cortez DA, Ueda-Nakamura T, Nakamura CV, Dias Filho BP. Res Microbiol; 2010 Sep 21; 161(7):534-40. PubMed ID: 20541606 [Abstract] [Full Text] [Related]